Cancer BiologybioRxivPreprint
CRISPR screening reveals SYCP3 as a key driver of metastasis in prostate cancer
María Rodrigo‐Faus, Inés del Monte-García, Marina Hermosilla-Trespaderne…·Álvaro Gutiérrez-Uzquiza
This study identifies SYCP3 as a driver of prostate cancer metastasis through CRISPR screening and shows its role in invasion, adhesion, and radiotherapy resistance.
DOI 10.1101/2025.01.30.629925